The Fas Death Signaling Pathway Connecting Reactive Oxygen Species Generation and FLICE Inhibitory Protein Down-Regulation1

Fas-mediated apoptosis plays an important role in normal tissue homeostasis, and disruption of this death pathway contributes to many human diseases. Induction of apoptosis via Fas activation has been associated with reactive oxygen species (ROS) generation and down-regulation of FLICE inhibitory protein (FLIP); however, the relationship between these two events and their role in Fas-mediated apoptosis are unclear. We show herein that ROS are required for FLIP down-regulation and apoptosis induction by Fas ligand (FasL) in primary lung epithelial cells. ROS mediate the down-regulation of FLIP by ubiquitination and subsequent degradation by proteasome. Inhibition of ROS by antioxidants or by ectopic expression of ROS-scavenging enzymes glutathione peroxidase and superoxide dismutase effectively inhibited FLIP down-regulation and apoptosis induction by FasL. Hydrogen peroxide is a primary oxidative species responsible for FLIP down-regulation, whereas superoxide serves as a source of peroxide and a scavenger of NO, which positively regulates FLIP via S-nitrosylation. NADPH oxidase is a key source of ROS generation induced by FasL, and its inhibition by dominant-negative Rac1 expression or by chemical inhibitor decreased the cell death response to FasL. Taken together, our results indicate a novel pathway of FLIP regulation by an interactive network of reactive oxygen and nitrogen species that provides a key mechanism of apoptosis regulation in Fas-induced cell death and related apoptosis disorders.

[1]  Wendy L. Allen,et al.  Cellular FLICE-inhibitory protein regulates chemotherapy-induced apoptosis in breast cancer cells , 2007, Molecular Cancer Therapeutics.

[2]  W. Yeh,et al.  An antiapoptotic protein, c‐FLIPL, directly binds to MKK7 and inhibits the JNK pathway , 2006, The EMBO journal.

[3]  A. Safa,et al.  Cellular FLICE-like inhibitory protein (c-FLIP): a novel target for Taxol-induced apoptosis. , 2006, Biochemical pharmacology.

[4]  P. Krammer,et al.  The c-FLIP–NH2 terminus (p22-FLIP) induces NF-κB activation , 2006, The Journal of experimental medicine.

[5]  P. Jansen,et al.  Superoxide anions and hydrogen peroxide induce hepatocyte death by different mechanisms: involvement of JNK and ERK MAP kinases. , 2006, Journal of hepatology.

[6]  P. Witting,et al.  Protective effect of a synthetic anti‐oxidant on neuronal cell apoptosis resulting from experimental hypoxia re‐oxygenation injury , 2006, Journal of neurochemistry.

[7]  Liying Wang,et al.  Nitric Oxide Negatively Regulates Fas CD95-induced Apoptosis through Inhibition of Ubiquitin-Proteasome-mediated Degradation of FLICE Inhibitory Protein* , 2005, Journal of Biological Chemistry.

[8]  John E. Eriksson,et al.  Rapid Turnover of c-FLIPshort Is Determined by Its Unique C-terminal Tail* , 2005, Journal of Biological Chemistry.

[9]  D. Lawrence,et al.  Selective Knockdown of the Long Variant of Cellular FLICE Inhibitory Protein Augments Death Receptor-mediated Caspase-8 Activation and Apoptosis* , 2005, Journal of Biological Chemistry.

[10]  Liying Wang,et al.  Regulation of Fas (CD95)‐induced apoptotic and necrotic cell death by reactive oxygen species in macrophages , 2005, Journal of cellular physiology.

[11]  Michael Karin,et al.  Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases , 2005, Cell.

[12]  K. Watanabe,et al.  Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP , 2005, Cell Death and Differentiation.

[13]  R. Flavell,et al.  JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. , 2004, Genes & development.

[14]  Francesca Zazzeroni,et al.  Ferritin Heavy Chain Upregulation by NF-κB Inhibits TNFα-Induced Apoptosis by Suppressing Reactive Oxygen Species , 2004, Cell.

[15]  G. Voutsinas,et al.  c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations. , 2004, Urology.

[16]  Liying Wang,et al.  Transport and Hydrolysis of Enkephalins in Cultured Alveolar Epithelial Monolayers , 1993, Pharmaceutical Research.

[17]  H. Hsu,et al.  The Fas Signaling Connection Between Autoimmunity and Embryonic Lethality , 2004, Journal of Clinical Immunology.

[18]  V. Borutaite,et al.  Nitric oxide induces apoptosis via hydrogen peroxide, but necrosis via energy and thiol depletion. , 2003, Free radical biology & medicine.

[19]  H. Daniel,et al.  Nitric oxide suppresses apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions , 2003, International journal of cancer.

[20]  Takahiro Doi,et al.  NF‐κB inhibits TNF‐induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death , 2003, The EMBO journal.

[21]  O. Tirosh,et al.  Potentiation of Fas-mediated apoptosis by attenuated production of mitochondria-derived reactive oxygen species , 2003, Cell Death and Differentiation.

[22]  E. White,et al.  E1A Sensitizes Cells to Tumor Necrosis Factor Alpha by Downregulating c-FLIPS , 2003, Journal of Virology.

[23]  高橋 祥.  Fas-mediated apoptosome formation is dependent on reactive oxygen species derived from mitochondrial permeability transition in Jurkat cells , 2003 .

[24]  K. Kuwano,et al.  Resistance to Fas-mediated apoptosis in human lung fibroblast , 2002, European Respiratory Journal.

[25]  Xiaolu Yang,et al.  c‐FLIPL is a dual function regulator for caspase‐8 activation and CD95‐mediated apoptosis , 2002, The EMBO journal.

[26]  M. Sporn,et al.  An Inducible Pathway for Degradation of FLIP Protein Sensitizes Tumor Cells to TRAIL-induced Apoptosis* , 2002, The Journal of Biological Chemistry.

[27]  P. Krammer,et al.  FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated Apoptosis , 2001, Molecular and Cellular Biology.

[28]  B. Malassagne,et al.  The superoxide dismutase mimetic MnTBAP prevents Fas-induced acute liver failure in the mouse. , 2001, Gastroenterology.

[29]  E. Chi,et al.  Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. , 2001, The American journal of pathology.

[30]  Y. Hamada,et al.  Cisplatin (CDDP) sensitizes human osteosarcoma cell to Fas/CD95‐mediated apoptosis by down‐regulating FLIP‐L expression , 2000, International journal of cancer.

[31]  K. Irani,et al.  Rac1 inhibits TNF‐α‐induced endothelial cell apoptosis: dual regulation by reactive oxygen species , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  F. Martinon,et al.  The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways , 2000, Current Biology.

[33]  S. Nagata,et al.  Fas ligand-induced apoptosis. , 1999, Annual review of genetics.

[34]  R. Offringa,et al.  Immune Escape of Tumors in Vivo by Expression of Cellular Flice-Inhibitory Protein , 1999, The Journal of experimental medicine.

[35]  S. Nagata,et al.  Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. , 1999, The Journal of clinical investigation.

[36]  Y. Goltsev,et al.  Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.

[37]  R. Siegel,et al.  Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.

[38]  J. Tschopp,et al.  Inhibition of fas death signals by FLIPs. , 1998, Current opinion in immunology.

[39]  W. Fiers,et al.  Dual Signaling of the Fas Receptor: Initiation of Both Apoptotic and Necrotic Cell Death Pathways , 1998, The Journal of experimental medicine.

[40]  J. Bertin,et al.  Death-effector Filaments: Novel Cytoplasmic Structures that Recruit Caspases and Trigger Apoptosis , 1998, The Journal of cell biology.

[41]  G. Salvesen,et al.  Caspases: Intracellular Signaling by Proteolysis , 1997, Cell.

[42]  A. Chinnaiyan,et al.  Ultraviolet Radiation-induced Apoptosis Is Mediated by Activation of CD-95 (Fas/APO-1)* , 1997, The Journal of Biological Chemistry.

[43]  Margot Thome,et al.  Inhibition of death receptor signals by cellular FLIP , 1997, Nature.

[44]  C. Janeway,et al.  The Role of Fas in Autoimmune Diabetes , 1997, Cell.

[45]  J. Zweier,et al.  Mitogenic Signaling Mediated by Oxidants in Ras-Transformed Fibroblasts , 1997, Science.

[46]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[47]  P. Galle,et al.  Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. , 1997, The Journal of clinical investigation.

[48]  V. Ferrans,et al.  rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation , 1996, Molecular and cellular biology.

[49]  O. Linderkamp,et al.  Fas‐induced programmed cell death is mediated by a Ras‐regulated O2− synthesis , 1996, Immunology.

[50]  V. Ferrans,et al.  Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. , 1996, The Biochemical journal.

[51]  I. Herr,et al.  Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells , 1996, Nature Medicine.

[52]  P. Krammer,et al.  Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120 , 1995, Nature.

[53]  D. Green,et al.  FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. , 1995, Immunity.

[54]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[55]  S. Nagata,et al.  No requirement of reactive oxygen intermediates in Fas‐mediated apoptosis , 1994, FEBS letters.

[56]  G M Bokoch,et al.  Regulation of the human neutrophil NADPH oxidase by the Rac GTP-binding proteins. , 1994, Current opinion in cell biology.

[57]  N. Jenkins,et al.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.

[58]  J. Crapo,et al.  Biology of disease: free radicals and tissue injury. , 1982, Laboratory investigation; a journal of technical methods and pathology.